Day: August 28, 2025

Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors

Written by Customer Service on August 28, 2025. Posted in Public Companies.

WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has agreed to appoint Abhinav “Abi” Jain as an independent member of its Board of Directors, subject to customary onboarding procedures. Mr. Jain will be a Class III director with an initial term expiring at the Company’s 2026 Annual Meeting of Stockholders and serve on the Board’s Compensation Committee and Nominating and Corporate Governance Committee. In connection with Mr. Jain’s planned appointment, Eagle entered into a cooperation agreement (the “Agreement”) with Nantahala Capital Management, LLC (together with its affiliates, “Nantahala”), a holder of approximately 38% of the Company’s outstanding shares. Pursuant to the Agreement, Eagle has also agreed to appoint a second...

Central 1 reports second quarter 2025 financial results

Written by Customer Service on August 28, 2025. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) — Central 1 Credit Union (Central 1) today reported its 2025 second quarter financials, reflecting strong results in the treasury line of business and investments for growth of the payments line of business. “Our results are showing steady performance for 2025, reflecting the renewed focus on our core payments and treasury lines of business since transferring digital banking operations to Intellect Design in the first quarter of 2025,” said Sheila Vokey, President & CEO of Central 1. “In the first half of the year, we’ve made meaningful investment and progress to evolve our business and to strengthen our position as a trusted aggregated services provider for Canadian credit unions and other financial service organizations.” Second quarter 2025 compared with the second...

Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update

Written by Customer Service on August 28, 2025. Posted in Earnings Releases And Operating Results.

All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced its financial results for the three months ended June 30, 2025 (“Q2 2025”), and provided an update on recent corporate developments. Q2 2025 Financial HighlightsReported a net loss of $2,916,944. Research and development (R&D) expenses were $1,611,985, reflecting continued advancement of AI-powered drug candidates. General and administrative (G&A) expenses were $1,213,489 including investor & public relations and exchange-related fees. Operating expense cash burn (non-IFRS measure) was approximately...

UPDATE – Carlsmed® Reports Second Quarter 2025 Financial Results

Written by Customer Service on August 28, 2025. Posted in Earnings Releases And Operating Results.

Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M – $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the second quarter ended June 30, 2025. “Our strong commercial performance was driven by the continued adoption of our highly differentiated AI-enabled aprevo® technology platform and growing recognition of its ability to deliver more favorable patient outcomes than legacy devices,” said Mike Cordonnier, Chairman and CEO of Carlsmed. “Building upon our momentum in personalized lumbar fusion surgery, in July we successfully completed the first personalized cervical spine surgery using our aprevo® technology...

Summary Notice of Proposed Settlement of Derivative Actions

Written by Customer Service on August 28, 2025. Posted in Public Companies.

OVERLAND PARK, Kan., Aug. 28, 2025 (GLOBE NEWSWIRE) — Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, today released the following notice: A U.S. District Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMPASS MINERALS INTERNATIONAL, INC. (“COMPASS” OR THE “COMPANY”) COMMON STOCK AS OF JULY 14, 2025 (THE “RECORD DATE”). IF YOU WERE A RECORD OR BENEFICIAL OWNER OF THE COMPANY’S COMMON STOCK AS OF THE RECORD DATE, PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY, AS YOUR RIGHTS MAY BE AFFECTED BY PROCEEDINGS IN THE ABOVE-REFERENCED LITIGATION. PLEASE TAKE NOTICE that the above-captioned consolidated derivative actions are being settled on the terms set forth in a Stipulation and Agreement of Settlement dated July...

Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date

Written by Customer Service on August 28, 2025. Posted in Public Companies.

Alternate Price Condition of Warrants Satisfied on Thursday, August 28, 2025 Warrants Must be Exercised Prior to 5:00 p.m. New York City Time on Friday, August 29, 2025 Last Day of Warrant Trading on Nasdaq is Friday, August 29, 2025 Notice of Guaranteed Delivery is Available for Warrant Exercises 12.6 Million Warrants Already Exercised for Approximately $110.1 Million Gross Proceeds FREMONT, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) — Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced that the alternate price condition applicable to the Company warrants currently traded on Nasdaq under ENVXW (the “Warrants”) was satisfied on August 28, 2025 in accordance with the Warrant Agreement, dated as of July 21, 2025, between Enovix and Computershare Trust Company...

Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase

Written by Customer Service on August 28, 2025. Posted in Public Companies.

– Mid-Atlantic ACO Realized Highest Savings Rate of All ACOs with 40,000+ Attributed Lives – Company Increases Adjusted EBITDA Guidance for Full-Year 2025 ARLINGTON, Va., Aug. 28, 2025 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $233.1 million through the Medicare Shared Savings Program (MSSP) for the 2024 performance year, a 32% increase from 2023. The nine ACOs (collectively, Privia Quality Network or PQN) managed over $2.5 billion in healthcare benchmark spend through approximately 3,280 providers delivering high-value, cost-efficient care to approximately 194,700 Medicare beneficiaries in 2024. “Our strong performance in the 2024 Medicare Shared Savings Program underscores the effectiveness of our physician-led approach,”...

Acuity to Announce Fiscal 2025 Fourth-Quarter and Full-Year Results on October 1, 2025

Written by Customer Service on August 28, 2025. Posted in Public Companies.

ATLANTA, Aug. 28, 2025 (GLOBE NEWSWIRE) — Acuity Inc. (NYSE: AYI) (the “Company”) will release fiscal 2025 fourth-quarter and full-year results on Wednesday, October 1, 2025 at 6:00 a.m. ET, followed by a conference call at 8:00 a.m. ET. Neil Ashe, Chief Executive Officer of Acuity Inc., will lead the call. The webcast, earnings release, and supplemental presentation can be accessed via the Investor Relations section of the Company’s website at www.investors.acuityinc.com on Wednesday, October 1, 2025. The online replay will remain available for a limited time following the call. A replay of the call will also be posted to the Investor Relations site two hours after the completion of the conference call and will be archived on the website. To learn more about Acuity, please visit the Company’s website. About Acuity Acuity...

AIP Realty Trust Announces Second Quarter 2025 Results

Written by Customer Service on August 28, 2025. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) — AIP Realty Trust (the “Trust” or “AIP Realty”) (TSXV:AIP.U) today announced its financial results for the three and six months ended June 30, 2025. All dollar amounts are stated in U.S. dollars. Q2 2025 HighlightsInvestment property revenue for the three ended June 30, 2025 was $150,403, compared to $152,591 in the same period in 2024, a decrease of $2,188, or 1%. The decline in investment property revenue was mainly due to a decline in parking revenue from a 2024 lease expiration that included a large parking agreement component and normal turnover that resulted in the vacancy of one unit starting in mid April 2025, partially offset by increased other revenue generated by tenant move-out charges. Investment property operating expense for the three months ended June...

ParaZero Announces First Half of 2025 Financial Results

Written by Customer Service on August 28, 2025. Posted in Earnings Releases And Operating Results.

Sales increased by approximately 27% compared to the same period in 2024 KFAR SABA, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, reported today its financial results for the six months ended June 30, 2025. Key Highlights of ParaZero’s Achievements in the First Half of 2025 & Recent Updates: Financial and Corporate Updates:Sales increased by 26.6% to $357,979 for the six months ended June 30, 2025. ParaZero raised approximately $3.1 million and $2.2 million in gross proceeds from registered direct offerings in February 2025 and August 2025, respectively Appointed Ariel Alon, a senior UAV executive, as company’s CEO.Counter-Drone...

Day: August 28, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals